#USA #FutureCeuticals #Momence #NeuroRush #Aura Scientific

FutureCeuticals Initiates Legal Proceedings Against Aura Scientific

In a significant legal move, VDF FutureCeuticals, Inc. has filed a lawsuit against Aura Scientific, accusing the latter of infringing multiple patents related to its ingredient NeuroRush. This brain performance product, derived from whole coffee fruit extract, is alleged to violate FutureCeuticals’ established intellectual property rights concerning coffee fruit technology, particularly formulations aimed at enhancing cognitive performance metrics.

The lawsuit seeks monetary damages, a declaration of willful infringement, and an immediate cessation of sales related to the infringing ingredient. FutureCeuticals, a pioneer in the whole coffee fruit market, has held numerous patents over these extracts for years, with a portfolio that includes patents on compositions specifically targeting brain performance—a development based on extensive clinical trials commissioned and published by the company.

J. Randal Wexler, Vice President and General Counsel of FutureCeuticals, expressed strong sentiments about the situation, stating, “Aura Scientific’s NeuroRush ingredient does not bring anything new to the table; it merely rides on the coattails of FutureCeuticals' reputable science and patented discoveries in the coffee fruit space. This glaring violation not only affects us but also undermines our many licensees who currently market products containing our authentic ingredients like CognatiQ® and NeuroFactor®.”

The lawsuit’s primary aim is to halt this infringement at its source; FutureCeuticals is committed to taking all necessary measures to eliminate the offending ingredient from the marketplace. Wexler further emphasized, “At this stage, we have no choice but to aggressively protect and defend our intellectual property rights and the interests of our clients in a legal setting.”

Notably, several major and minor dietary supplement brands have recently rolled out products incorporating Aura Scientific's NeuroRush in their formulations. Wexler cautioned these manufacturers, saying, “We strongly urge product makers to carefully reconsider their choice of using NeuroRush in their products, given FutureCeuticals' clear intellectual property rights. We take our commitment to safeguarding our intellectual property for ourselves and our customers very seriously.”

VDF FutureCeuticals, Inc. stands as a leader in the research, development, and manufacturing of fruit, vegetable, and grain-based powders and extracts designed for the functional foods, beverages, and dietary supplement markets. The company focuses on harnessing the synergistic potential of plants by discovering and exploring innovative, nutrient-rich plant-based ingredients. Products like CognatiQ® and NeuroFactor® are exclusive offerings from FutureCeuticals.



Moving forward, the outcome of this legal battle may have significant implications for both companies involved and the broader dietary supplement industry, particularly regarding intellectual property rights and the protection of innovation within the market.